EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation

Tandis Parvizi iD, Sigrid Klotz, Omar Keritam, Haluk Caliskan, Sophie Imhof, Theresa König, Lukas Haider, Tatjana Traub-Weidinger, Matias Wagner iD, Theresa Brunet iD, Melanie Brugger iD, Alexander Zimprich iD und 4 weitere

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52075 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Tandis Parvizi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Membrane Transport Proteins, Cell Cycle Proteins, Frontotemporal Dementia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mutations in the gene encoding for optineurin ( OPTN ) have been reported in the context of different neurodegenerative diseases including the amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) spectrum. Based on single case reports, neuropathological data in OPTN mutation carriers have revealed transactive response DNA‐binding protein 43 kDa (TDP‐43) pathology, in addition to accumulations of tau and alpha‐synuclein. Herein, we present two siblings from a consanguineous family with a homozygous frameshift mutation in the OPTN gene and different clinical presentations.

Methods

Both affected siblings underwent (i) clinical, (ii) neurophysiological, (iii) neuropsychological, (iv) radiological, and (v) laboratory examinations, and (vi) whole‐exome sequencing (WES). Postmortem histopathological examination was conducted in the index patient, who deceased at the age of 41.

Results

The index patient developed rapidly progressing clinical features of upper and lower motor neuron dysfunction as well as apathy and cognitive deterioration at the age of 41. Autopsy revealed an ALS‐FTLD pattern associated with prominent neuronal and oligodendroglial TDP‐43 pathology, and an atypical limbic 4‐repeat tau pathology reminiscent of argyrophilic grain disease. The brother of the index patient exhibited behavioral changes and mnestic deficits at the age of 38 and was diagnosed with behavioral FTD 5 years later, without any evidence of motor neuron dysfunction. WES revealed a homozygous frameshift mutation in the OPTN gene in both siblings (NM_001008212.2: c.1078_1079del; p.Lys360ValfsTer18).

Interpretation

OPTN mutations can be associated with extensive TDP‐43 pathology and limbic‐predominant tauopathy and present with a heterogeneous clinical phenotype within the ALS‐FTD spectrum within the same family.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMembrane Transport ProteinsCell Cycle ProteinsFrontotemporal DementiaHumansMaleAdultFemalePedigreeTranscription Factor TFIIIASiblingsFrameshift MutationHomozygote

Substanzen

OPTN protein, humanMembrane Transport ProteinsCell Cycle ProteinsTranscription Factor TFIIIA

Autor:innen und Institutionen

  • Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Vienna, Austria.
  • Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.
  • Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Tandis Parvizi, Matias Wagner, Theresa Brunet, Melanie Brugger, Alexander Zimprich, Jakob Rath, Ellen Gelpi

Zitieren

APA

Parvizi, T., Klotz, S., Keritam, O., Caliskan, H., Imhof, S., König, T., Haider, L., Traub-Weidinger, T., Wagner, M., Brunet, T., Brugger, M., Zimprich, A., Rath, J., Stögmann, E., Gelpi, E., & Cetin, H. (2024). Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52075

Vancouver

Parvizi T, Klotz S, Keritam O, Caliskan H, Imhof S, König T, et al. Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52075

BibTeX
@article{Parvizi2024,
  author = {Parvizi, Tandis and Klotz, Sigrid and Keritam, Omar and Caliskan, Haluk and Imhof, Sophie and König, Theresa and Haider, Lukas and Traub-Weidinger, Tatjana and Wagner, Matias and Brunet, Theresa and Brugger, Melanie and Zimprich, Alexander and Rath, Jakob and Stögmann, Elisabeth and Gelpi, Ellen and Cetin, Hakan},
  title = {Clinical heterogeneity within the ALS‐FTD spectrum in a family with a homozygous optineurin mutation},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52075}
}
Kostenlos starten →